FeesSafety
Pluang+

Altrova Health to present growth strategy at Toronto's ArcStone-Kingswood Summit on Sept 16, 2026

Market News
14 Sep 2026
Newsfile Corp
View Source
Bullish
Altrova Health to present growth strategy at Toronto's ArcStone-Kingswood Summit on Sept 16, 2026

Altrova Health Inc. announced it will participate in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026. CEO Geoff Benic will present the company's recent milestones and future growth plans. The summit gathers growth companies and investors for presentations, networking, and one-on-one meetings, providing a platform for Altrova to showcase its health solutions portfolio. This event could enhance Altrova's visibility and attract potential investors for its expanding product line in health detection, protection, treatment, and wellness.

More News

Ipsos reports 2.0% organic growth in Q3, upgrades 2026 growth outlook amid AI and digital expansion.

Ipsos reports 2.0% organic growth in Q3, upgrades 2026 growth outlook amid AI and digital expansion.

Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...

Company Fundamentals
Bullish
1 hour ago
Ipsos reports 2.0% organic growth in Q3 2026, driven by EMEA, China, and Citizens segment.

Ipsos reports 2.0% organic growth in Q3 2026, driven by EMEA, China, and Citizens segment.

Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...

Company Fundamentals
Bullish
1 hour ago
Signify posts Q3 profit growth despite sales dip, confirms full-year margin outlook

Signify posts Q3 profit growth despite sales dip, confirms full-year margin outlook

Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...

Company Fundamentals
Bullish
1 hour ago
Sika reports 4.8% sales growth in nine months and confirms 2026 guidance amid strong market gains and acquisitions.

Sika reports 4.8% sales growth in nine months and confirms 2026 guidance amid strong market gains and acquisitions.

Sika AG posted a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite currency headwinds. The company saw organic growth of 3.5% and improved material margins to 55.4%, with EBITDA rising 1.9% t...

Company Fundamentals
Bullish
3 hours ago
Sika posts 4.8% sales growth in 9 months, confirms 2026 forecast with strong profit and acquisitions.

Sika posts 4.8% sales growth in 9 months, confirms 2026 forecast with strong profit and acquisitions.

Sika reported a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite a negative currency effect. The company improved its material margin to 55.4% and maintained an EBITDA margin of 19.2%, with ...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App